TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.77
+0.17 (1.77%)
At close: Mar 9, 2026, 4:00 PM EDT
9.67
-0.10 (-1.02%)
After-hours: Mar 9, 2026, 4:00 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.96 million as of March 9, 2026. Its market cap has increased by 30.50% in one year.
Market Cap
8.96M
Enterprise Value
5.94M
1-Year Change
30.50%
Ranking
Category
Stock Price
$9.77
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.96M, a decrease of -81.28%. That is a compound annual growth rate of -30.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.80M | 40.56% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 10.17M |
| BioVie | 10.10M |
| CollPlant Biotechnologies | 9.53M |
| NuCana | 9.16M |
| SeaStar Medical Holding | 9.08M |
| Iterum Therapeutics | 8.49M |
| Bolt Biotherapeutics | 8.41M |
| Alaunos Therapeutics | 8.15M |